Trigeminal Neuralgia - Drug Pipeline Landscape, 2022

Trigeminal Neuralgia (TN), also known as tic douloureux, is a condition that causes painful sensations similar to an electric shock on one side of the face. The pain typically involves the lower face and jaw, although sometimes it affects the area around the nose and above the eye.

There are two types of TN primary and secondary. Primary trigeminal Neuralgia has been linked to the compression of the nerve. Trigeminal Neuralgia is caused by a blood vessel exerting pressure on the nerve near your brain stem. This condition can also be caused by a tumor or lesion that compresses nerves. Other known causes a swollen blood vessel or tumor that puts pressure on the nerve and multiple sclerosis.

Diagnosis of Trigeminal Neuralgia will depend on the type and location of the pain an. Doctor will first evaluate medical history and perform a physical exam. A neurological examination and magnetic resonance imaging (MRI) can also be suggested for diagnosis.

Read more about Trigeminal Neuralgia - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/trigeminal-neuralgia-drug-pipeline-landscape-2022/

Report Highlights:

Global Insight Service's, Trigeminal Neuralgia - Drug Pipeline Landscape, 2022 report provides an overview of the Trigeminal Neuralgia pipeline drugs. This report covers detailed insights on Trigeminal Neuralgia drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Trigeminal Neuralgia pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology:

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS31040/

Scope:

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Key Players:

- Amgen Inc
- Biogen
- Biohaven Pharmaceuticals, Inc.
- Noema Pharma AG.

Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS31040/

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.